| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
C-reactive protein | 0.299 | 0.962 | 3.7E-03 |
|
disease | 0.090 | None | 0.889 | 9 | 1 | 2016 | 2020 | ||||||||
|
single-strand-selective monofunctional uracil-DNA glycosylase 1 | 0.322 | 0.923 | 4.5E-04 |
|
disease | 0.070 | None | 1.000 | 7 | 0 | 2017 | 2019 | ||||||||
|
grancalcin | 0.590 | 0.731 | 1.4E-04 |
|
disease | 0.060 | None | 1.000 | 6 | 0 | 2017 | 2019 | ||||||||
|
pentraxin 3 | 0.457 | 0.808 | 7.0E-05 |
|
disease | 0.060 | None | 0.833 | 6 | 0 | 2014 | 2019 | ||||||||
|
RNA binding motif protein 45 | 0.383 | 0.846 | 2.1E-10 |
|
disease | 0.060 | None | 1.000 | 6 | 0 | 1992 | 2015 | ||||||||
|
Fc fragment of IgG receptor IIa | 0.480 | 0.769 | 2.0E-06 |
|
disease | 0.050 | None | 0.800 | 5 | 0 | 2013 | 2017 | ||||||||
|
acrosin | 0.493 | 0.846 | 1.2E-02 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 2012 | 2019 | ||||||||
|
Fc fragment of IgG receptor IIIa | 0.432 | 0.962 | 3.7E-06 |
|
disease | 0.040 | None | 0.750 | 4 | 0 | 2013 | 2018 | ||||||||
|
interleukin 6 receptor | 0.471 | 0.846 | 3.2E-05 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2017 | 2019 | ||||||||
|
major histocompatibility complex, class I, A | 0.370 | 0.846 | 1.3E-03 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 1982 | 2007 | ||||||||
|
major histocompatibility complex, class II, DQ alpha 1 | 0.416 | 0.846 | 2.4E-02 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 1992 | 2017 | ||||||||
|
interleukin 10 | 0.281 | 0.923 | 5.9E-03 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2017 | 2019 | ||||||||
|
MHC class I polypeptide-related sequence A | 0.473 | 0.846 | 5.0E-03 |
|
disease | 0.030 | None | 1.000 | 3 | 2 | 1998 | 2018 | ||||||||
|
major histocompatibility complex, class II, DP beta 1 | 0.453 | 0.923 | 5.3E-10 |
|
disease | 0.030 | None | 0.667 | 3 | 0 | 1992 | 2017 | ||||||||
|
interleukin 23 subunit alpha | 0.415 | 0.846 | 0.36 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2016 | 2017 | ||||||||
|
nucleotide binding oligomerization domain containing 2 | 0.423 | 0.923 | 2.0E-30 |
|
disease | 0.020 | None | 1.000 | 2 | 1 | 2012 | 2013 | ||||||||
|
S100 calcium binding protein A8 | 0.430 | 0.962 | 0.14 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2018 | 2019 | ||||||||
|
vascular endothelial growth factor A | 0.266 | 0.923 | 2.4E-05 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2018 | 2019 | ||||||||
|
fibroblast growth factor 2 | 0.383 | 0.923 | 1.8E-02 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2019 | 2019 | ||||||||
|
heat shock protein family D (Hsp60) member 1 | 0.432 | 0.808 | 0.99 |
|
disease | 0.020 | None | 0.500 | 2 | 0 | 1998 | 2017 | ||||||||
|
vascular cell adhesion molecule 1 | 0.422 | 0.808 | 0.80 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2006 | 2019 | ||||||||
|
mechanistic target of rapamycin kinase | 0.343 | 0.885 | 1.00 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2018 | 2020 | ||||||||
|
protein tyrosine phosphatase non-receptor type 22 | 0.438 | 0.846 | 3.5E-21 |
|
disease | 0.020 | None | 0.500 | 2 | 2 | 2008 | 2019 | ||||||||
|
fibroblast growth factor 13 | 0.514 | 0.808 | 0.89 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2019 | 2019 | ||||||||
|
leukocyte immunoglobulin like receptor B3 | 0.805 | 0.269 | 3.1E-06 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2015 | 2017 |